Results 31 to 40 of about 2,450 (200)

Burden of drug use for gastrointestinal symptoms and functional gastrointestinal disorders in France: a national study using reimbursement data for 57 million inhabitants

open access: yesTherapeutic Advances in Gastroenterology, 2019
Background: Gastrointestinal therapeutic drugs (GTDs) are extensively prescribed. The aim of this study was to investigate the characteristics of GTD use in a large population: the French general health scheme beneficiaries (87% of the 66 million ...
Philippe Tuppin   +4 more
doaj   +1 more source

Bacillus clausii as adjunctive treatment for acute community-acquired diarrhea among Filipino children: a large-scale, multicenter, open-label study (CODDLE)

open access: yesTropical Diseases, Travel Medicine and Vaccines, 2019
Background Diarrhea is among the main causes of pediatric mortality in the Philippines. Probiotics have been shown to be beneficial in the management of acute diarrhea.
Jo-Anne A. de Castro   +2 more
doaj   +1 more source

Resolution of Levodopa/Dopa‐Decarboxylase Inhibitor—Associated Microscopic Colitis with Subcutaneous Foslevodopa/Foscarbidopa: A Case Series and Review of the Literature

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background Microscopic colitis (MC) typically presents with chronic, non‐bloody watery diarrhea. Diagnosis requires endoscopy with colonic mucosal biopsies. The etiology is multifactorial, with several medications implicated, although only a few cases have been attributed to oral levodopa/dopa‐decarboxylase inhibitor (LDDCI) therapy.
Romana Hintner   +10 more
wiley   +1 more source

Utilization of Patient-Reported Outcomes to Guide Symptom Management during Stereotactic Body Radiation Therapy for Clinically Localized Prostate Cancer

open access: yesFrontiers in Oncology, 2017
IntroductionUtilization of patient-reported outcomes (PROs) to guide symptom management during radiation therapy is increasing. This study focuses on the use of the Expanded Prostate Cancer Index Composite for Clinical Practice (EPIC-CP) as a tool to ...
Malika Danner   +7 more
doaj   +1 more source

A catastrophic confluence: Concurrent subarachnoid haemorrhage and acute mesenteric ischaemia

open access: yesSurgical Practice, EarlyView.
Abstract Background Acute mesenteric ischaemia (AMI) and subarachnoid haemorrhage (SAH) are life‐threatening emergencies with diametrically opposed treatment requirements regarding anticoagulation. This report describes a rare, complex case where both conditions occurred simultaneously, creating a significant therapeutic dilemma. Case presentation A 64‐
Ip Ki Fung Shavonne
wiley   +1 more source

Postcholecystectomy diarrhea: What relieves it? [PDF]

open access: yes, 2011
A trial of a bile acid binder such as cholestyramine or colestipol may benefit patients with postcholecystectomy diarrhea (strength of recommendation [SOR]: C, case series).
Danley, Tabitha, St. Anna, Leilani
core  

Medication Reconciliation in Outpatient Psychiatry: An Indicator of Communication With Primary Care? A Quantitative Descriptive Study

open access: yesJournal of Advanced Nursing, EarlyView.
ABSTRACT Aims To quantify medication discrepancies between an outpatient psychiatric service and general practitioners in northern France, and investigate general practitioner identification in psychiatric records. Design Quantitative, exploratory, retrospective, descriptive, monocentric study.
Gwladys Acoulon   +5 more
wiley   +1 more source

Hemolytic uremic syndrome (HUS) [PDF]

open access: yes, 2009
This issue of eMedRef provides information to clinicians on the pathophysiology, diagnosis, and therapeutics of hemolytic uremic ...
Smidt-Afek, Naomi
core  

Dorsal Genital Nerve Stimulation in Patients With Fecal Incontinence and Fecal Urgency: A Feasibility Study With the Novel UCon Neurostimulator

open access: yesNeurogastroenterology &Motility, EarlyView.
Dorsal genital nerve stimulation with the UCon neurostimulator was found to be safe and feasible. A 4‐week period of home stimulation resulted in a reduction of fecal incontinence episodes, a decrease in strong urgency episodes, and an improvement in bowel‐related questionnaires.
Louise Schmidt Grau   +5 more
wiley   +1 more source

Downstream Treatment Burden and Health‐Care Utilization Following Initiation of GLP‐1 Receptor Agonists or SGLT2 Inhibitors in Type 2 Diabetes

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 6, Page 5163-5173, June 2026.
ABSTRACT Aims Glucagon‐like peptide‐1 (GLP‐1) receptor agonists and sodium–glucose cotransporter 2 (SGLT2) inhibitors are widely used for the treatment of type 2 diabetes, yet their downstream consequences in routine clinical practice remain incompletely characterized.
Yazan Alhamdan   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy